Wire · opportunities
Labcorp Acquires MLM Medical Labs to Expand Clinical Trial Laboratory Network
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 9 September 2026 · Fusion42 review
Labcorp has acquired MLM Medical Labs, expanding its global central lab network across the US, Germany, and South Africa, enhancing its biomarker and specialty testing capabilities for clinical trials. This acquisition creates the only global central lab network with wholly owned operations spanning four continents, supporting complex multinational clinical studies and expanding access to specialized testing in key research regions.
This Wire brief sits within Fusion42's coverage of Biotech, and 2 sources have reported it between 8 Sep 2026 and 9 Sep 2026.
◆ ◆ The Wire takeaway
Labcorp now controls a unique global lab network across four continents, reshaping clinical trial services and opening new opportunities for specialists in biomarker testing and trial operations. You can capitalise on their expanded footprint by targeting sponsors needing consistent multinational trial support.
◆ Coverage
2 sources · first reported 8 Sep 2026 · latest 9 Sep 2026
◆ Related on Wire
◆ Topics